Industries > Healthcare > Healthcare Mergers & Acquisition Consulting

Healthcare Mergers & Acquisition Consulting

Approximately USD 500bn worth of M&A deals are waiting to happen. SGA can assist you in tapping into the right audience, tech due diligence, and healthcare intel, along with cutting down the lag phase from search to go to market.

Blogs | Wearable Tech: A Promise to Revolutionize Healthcare

Healthcare Mergers and Acquisitions (M&A) Consulting Services

Our coverage 

We, at SG Analytics (SGA), are different, as our team of experts believes in end-to-end solutions for M&A firms and are largely based on the process lifecycle. The healthcare mergers and acquisition consulting team assists clients with intelligence gathering, strategy identification, and peer deal alerts. Our analysts can assist with therapeutic-specific content, tech-specific content, tech penetration analysis, and market forecasts. We work in unison with the investment research team of SGA, which supports us with the required due diligence. Together as a team, we are unmatched and unstoppable.  

M&A firms and venture capitalists are on the lookout for new technologies and acquirers from developing and developed worlds in the pharmaceutical, life sciences, and devices segments. We specialize in identifying and analyzing new medical technology, patent cliffs, patent conflicts, new FDA and ANDA filings, peer competition, and more. 


Healthcare mergers and acquisition


Industry Leaders

SGA thrives by its brand promise Life is Possible, and is deemed as the most trusted healthcare market research consulting company.

12+ Languages

SGAs language capabilities involve Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (US/UK).

Data-Driven Insights

With our in-depth domain knowledge, expertise, and proven capabilities of delivering monetizable insights, we provide high-quality, efficient outputs.

End-To-End Solutioning

The in-house key opinion leader (KOL) capability of more than 700, along with analytical and ML/AI capabilities, helps in offering incredible competitive information.

Who We Work With


Whitepaper Market Entry in 2023

White Papers

Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

SGA Whitepaper Blue Ocean Strategy

White Papers

The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....

SGA Healthcare Whitepaper Healthcare Consulting & Analytics

White Papers

What Happens When You Invest in Healthcare Consulting and Analytics?

Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...

We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labelled research coverage.